We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Apple Inc | NASDAQ:AAPL | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.945 | -0.55% | 171.745 | 171.74 | 171.74 | 173.76 | 171.46 | 171.75 | 13,914,940 | 15:24:58 |
From Apr 2019 to Apr 2024
By Colin Kellaher
Johnson & Johnson on Tuesday said it has opened enrollment for "Heartline," a study in collaboration with Apple Inc. that will explore if a new iPhone app and heart-health features on the Apple Watch can help reduce the risk of stroke.
J&J said U.S. adults 65 years and older can join the study by downloading the Heartline Study app on an iPhone.
The company said the study will assess whether the Heartline app and the ECG app and irregular rhythm notification feature on the Apple Watch can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation, a common form of irregular heart rhythm that is a leading cause of stroke.
J&J and Apple early last year announced plans to collaborate on the earlier detection of atrial fibrillation.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
February 25, 2020 09:02 ET (14:02 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Apple Chart |
1 Month Apple Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
